Long Term Vitamin D Therapy in HCV Treated Patients

Summary

Treatment of hepatitis C virus (HCV) infection was carried out using pegylated interferon (PEG-IFN), ribavirin (RBV) and vitamin D (vit D) for 48 weeks in HCV genotypes 4a subjects. The purpose of this study is to determine the effect of vitamin D on liver affection in such patients.

Timeline

Start

2012-04

Primary completion

2013-04

Completion

2013-04

Drugs

Indications